Heck Capital Advisors, LLC Abbott Laboratories Transaction History

Heck Capital Advisors, LLC

$1.29 Trillion
Q3 2025

A detailed history of Heck Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Heck Capital Advisors, LLC holds 4,701 shares of ABT stock, worth $611,271. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,701

Previous 4,532 3.73%

Holding current value

$611,271

Previous $616 Million 2.15%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	BUY	$120.51 - $136.62 $20,366 - $23,088	169 Added 3.73%	4,701 $630 Million
Q2 2025 Jul 22, 2025	BUY	$123.95 - $138.08 $40,407 - $45,014	326 Added 7.75%	4,532 $616 Million
Q1 2025 May 12, 2025	BUY	$111.1 - $140.22 $467,286 - $589,765	4,206 New	4,206 $558 Million
Q4 2024 May 13, 2025	BUY	$111.93 - $119.39 $783 - $835	7 Added 0.17%	4,213 $477 Million
Q4 2024 Jan 23, 2025	BUY	$111.93 - $119.39 $876,411 - $934,823	7,830 New	7,830 $886 Million

Q3 2024 May 19, 2025	SELL	$100.07 - $118.13 $12,408 - $14,648	-124 Reduced 2.85%	4,223 $481 Million
Q2 2024 May 19, 2025	BUY	$100.73 - $112.44 $402 - $449	4 Added 0.09%	4,347 $452 Million
Q1 2024 May 19, 2025	SELL	$109.52 - $120.96 $5,804 - $6,410	-53 Reduced 1.21%	4,343 $494 Million
Q4 2023 May 19, 2025	SELL	$90.19 - $110.4 $36,076 - $44,160	-400 Reduced 8.34%	4,396 $484 Million
Q3 2023 May 19, 2025	BUY	$95.53 - $114.62 $56,362 - $67,625	590 Added 14.03%	4,796 $464 Million
Q2 2023 May 19, 2025	SELL	$100.78 - $112.29 $11,186 - $12,464	-111 Reduced 2.24%	4,853 $529 Million
Q1 2023 May 19, 2025	BUY	$96.86 - $114.01 $17,434 - $20,521	180 Added 3.76%	4,964 $503 Million
Q4 2022 May 19, 2025	BUY	$95.06 - $111.52 $41,921 - $49,180	441 Added 10.15%	4,784 $525 Million
Q3 2022 May 20, 2025	BUY	$96.76 - $112.03 $50,411 - $58,367	521 Added 12.39%	4,727 $457 Million
Q3 2022 May 19, 2025	BUY	$96.76 - $112.03 $203,679 - $235,823	2,105 Added 94.06%	4,343 $494 Million
Q2 2022 May 19, 2025	SELL	$102.07 - $123.37 $27,354 - $33,063	-268 Reduced 10.69%	2,238 $243 Million
Q1 2022 May 19, 2025	SELL	$114.02 - $139.04 $193,834 - $236,368	-1,700 Reduced 40.42%	2,506 $297 Million
Q4 2021 May 19, 2025	SELL	$115.53 - $141.46 $37,662 - $46,115	-326 Reduced 6.71%	4,535 $638 Million
Q3 2021 May 19, 2025	SELL	$116.66 - $129.06 $9,216 - $10,195	-79 Reduced 1.6%	4,861 $574 Million
Q2 2021 May 19, 2025	BUY	$105.79 - $124.53 $7,087 - $8,343	67 Added 1.37%	4,940 $573 Million
Q1 2021 May 19, 2025	SELL	$108.84 - $128.23 $13,278 - $15,644	-122 Reduced 2.44%	4,873 $584 Million
Q4 2020 May 19, 2025	SELL	$105.0 - $114.42 $210 - $228	-2 Reduced 0.04%	4,995 $547 Million
Q3 2020 May 19, 2025	BUY	$91.64 - $111.29 $72,487 - $88,030	791 Added 18.81%	4,997 $544 Million
Q2 2020 May 19, 2025	BUY	$76.57 - $98.0 $51,837 - $66,346	677 Added 41.21%	2,320 $212 Million
Q1 2020 May 19, 2025	SELL	$62.82 - $91.86 $161,007 - $235,437	-2,563 Reduced 60.94%	1,643 $130 Million

Others Institutions Holding ABT

# of Institutions

3,646

Shares Held

1.38B

Call Options Held

10.3M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Heck Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Heck Capital Advisors, LLC with notifications on news.

Account

Heck Capital Advisors, LLC Abbott Laboratories Transaction History